[Tree] Competition, Economic Resiliency

Version 0.08 (2024-06-04 17:52:33.365000)

updates: CCIA's advocacy for competition and economic resiliency in the Senate hearing

  • ➔
Version 0.07 (2024-04-15 16:18:18.567000)

updates: CCIA joins organizations in urging Biden Administration to recommit to strong digital trade rules

  • ➔
Version 0.06 (2024-03-06 17:16:51.014000)

updates: CCIA's advocacy for a competitive tech industry and comprehensive privacy legislation

  • ➔
Version 0.05 (2024-02-27 21:19:04.116000)

updates: Incorporated an opinion piece from the Times of San Diego highlighting concerns about the potential negative impact of expanding the IP waiver on the biotech industry and innovation

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.04 (2024-02-13 00:20:55.822000)

updates: Incorporated opposition from the US biopharma industry to the patent waiver proposal for COVID medications

  • ➔
  • ➔
  • ➔
  • ➔
Version 0.03 (2024-01-31 10:26:48.977000)

updates: Incorporated opposition from Montana biotech industry and additional information on the WTO petition to remove IP protections from Covid-19 treatments

  • ➔
  • ➔
  • ➔
  • ➔
Version 0.02 (2024-01-04 13:17:22.498000)

updates: Opposition from Montana biotech industry to IP waiver expansion

  • ➔
  • ➔
  • ➔
  • ➔
Version 0.01 (2023-12-15 13:44:57.564000)

updates: Montana biotech industry raises concerns about TRIPS waiver expansion

  • ➔
  • ➔
  • ➔
Version 0.0 (2023-11-22 05:59:11.755000)

updates:

  • ➔
  • ➔